Safety of percutaneous ultrasound-guided fine-needle aspiration of adrenal lesions in dogs: Perception of the procedure by radiologists and presentation of 50 cases by Pey, Pascaline et al.

S T ANDA RD AR T I C L E
Safety of percutaneous ultrasound-guided fine-needle
aspiration of adrenal lesions in dogs: Perception of the
procedure by radiologists and presentation of 50 cases
Pascaline Pey1 | Alessia Diana1 | Federica Rossi2 | Jeremy Mortier3 |
Ulrike Kafka4 | Stefanie Veraa5 | Anna Groth6 | Megan MacLellan7 |
Chiara Marin1 | Federico Fracassi1
1Department of Veterinary Medical Science,
Alma Mater Studiorum, University of Bologna,
Bologna, Italy
2Clinica Veterinaria dell'Orologio, Bologna,
Italy
3Service of Diagnostic Imaging, Small Animal
Teaching Hospital, Institute of Veterinary
Science, University of Liverpool, Neston,
United Kingdom
4James Cook University, Townsville,
Queensland, Australia
5Division of Diagnostic Imaging, Faculty of
Veterinary Medicine, Utrecht, The Netherlands
6North Downs Specialist Referrals,
Bletchingley, United Kingdom
7BluePearl Pet Hospital, Blaine, Maine
Correspondence
Pascaline Pey, Department of Veterinary
Medical Science, Alma Mater Studiorum,
University of Bologna, Via Tolara di Sopra
50, 40064 Ozzano Emilia, Bologna, Italy.
Email: pascaline.pey@unibo.it
Abstract
Background: Percutaneous ultrasound (US)-guided fine-needle aspiration (FNA) of
adrenal gland lesions is controversial in veterinary medicine.
Objective: To evaluate the frequency and radiologists' perception of the risk of the
procedure as well as determining the incidence of complications.
Methods: Retrospective study. A first survey was submitted by e-mail to all
board-certified radiologists of the American College of Veterinary Radiology
(ACVR) and European College of Veterinary Diagnostic Imaging (ECVDI). A sec-
ond survey was sent to radiologists who declared having performed the proce-
dure at least once in their career (observational cross-sectional case study).
Results: The first survey was sent to 977 diplomates and answered by 138. Of
138 diplomates, 40 currently performed the procedure and 98 did not; 44 of the
98 gave the hypertensive crisis risk in pheochromocytoma as a reason. To the sec-
ond survey, 12 of 65 responded positively; 50 dogs with 58 lesions were recruited,
including 23 pheochromocytomas. Complications were reported in 4 of 50 dogs;
3 hemorrhages (1 mild and 1 moderate) and 1 death from acute respiratory distress
syndrome (possibly related to laryngeal paralysis). No hypertensive crisis was
reported. There was no relationship between the method of FNA/type of needle
used and occurrence of complications. Based on the recollection of these 65 radiolo-
gists, who performed approximately 200 FNA of adrenal lesions, a death rate of
approximately 1% was estimated.
Conclusions and Clinical Importance: Percutaneous US-guided FNA of adrenal
lesions can be considered a minimally risky procedure, despite the negative percep-
tion by radiologists.
Abbreviations: ACVR, American College of Veterinary Radiology; ALP, alkaline phosphatase; CT, computed tomography; ECVDI, European College of Veterinary Diagnostic Imaging; FNA, fine-
needle aspiration; US, ultrasound.
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1 | INTRODUCTION
In dogs, fine-needle aspiration (FNA), performed percutaneously
under ultrasound (US) guidance, represents the most used and least
invasive technique for the collection of cytological samples of abdomi-
nal organs.1,2 Adrenal cytology is able to discriminate the origin (corti-
cal or medullary) of an adrenal neoplasm with a high diagnostic
accuracy (90%-100%).3 The evaluation of an adrenal cytological sam-
ple can therefore be a major benefit in the diagnostic approach of
adrenal lesions, even though inaccurate in distinguishing benign from
malignant lesions.3
However, performing percutaneous US-guided FNA of adrenal
lesions is controversial and remains an important debate in veterinary
medicine.4-7 The risk of hypertensive crisis discourages veterinarians
from the procedure,4-7 although evidence is only based on reports in the
human literature.8-11 In veterinary medicine, risk assessment is anecdotal.
Bleeding, hematic contamination of the sample, and fear of spreading
the neoplasm along the needle path are other concerns that may limit
the general use of US-guided FNA of adrenal lesions.12-16 A recent paper
evaluated the clinical safety of this procedure.17 One complication (ven-
tricular tachycardia) was reported out of 23 percutaneous US-guided
FNA of adrenal lesions.17 The authors concluded that the procedure was
relatively safe, including the 10 pheochromocytomas sampled.17
In dogs, incidental masses of adrenal glands (AGs) are frequently
detected on abdominal US and computed tomography (CT), with a
prevalence of 4% and 9%, respectively.18,19 These can be primary
tumors such as cortical adenoma, cortical carcinoma, pheochromocy-
toma, or metastases.7,20,21 Potential differential diagnoses also include
macronodular hyperplasia, cysts, granuloma, hematoma, and
myelolipomas.20,21 Following adrenal lesion detection, it is crucial to
determine its potential functionality (secreting versus nonsecreting),
its origin (epithelial or neuroendocrine), its biological nature (malignant
or benign), and its connection with adjacent vessels/organs.4-6,22-24
History, clinical signs, clinicopathological findings, endocrine tests and
US,25,26 contrast-enhanced US,27-31 and CT32,33 can assist in
predicting the functional aspect of an adrenal lesion and in differenti-
ating between a benign and malignant process. The aforementioned
imaging modalities can provide an estimate of potential malignancy
and can be extremely helpful in selecting the best therapeutic
approach, but they cannot predict the histological type of the adrenal
lesion. Several situations might complicate the diagnostic approach.
Secretory masses, in particular pheochromocytoma, can produce an
insufficient amount of hormone and therefore less characteristic clini-
cal signs and equivocal endocrine testing.4,5,22-24 This confuses their
identity with that of a nonsecretory tumor. Nonsecreting adrenal
masses, in turn, are silent from a biochemical point of view and may
complicate the diagnostic workup.21 Different types of primary
tumors may coexist, or each AG may be the site of a primary
tumor.34-37 As the preoperative treatment38,39 and surgical approach
differs from one adrenal tumor to another,40-45 prior knowledge of
the tumor type before surgery is relevant and desirable.
The main objectives of this study were (1) to evaluate the fre-
quency of percutaneous US-guided FNA of adrenal lesions performed
by veterinary radiologists, radiologists' opinion about the procedure,
and (2) to determine the incidence of adverse effects associated with it.
2 | MATERIALS AND METHODS
A multicenter retrospective study involving board-certified veterinary
radiologists was conducted. Two consecutive online surveys, using a
web-based application (Google forms, Google LLC, Mountain View,
California) were distributed via e-mail. To collect the data, a dedicated
e-mail account was created. Access to the data was password protec-
ted. Only 1 author had knowledge of the password. Anonymized
results were then exported in a spreadsheet opened with a dedicated
program (Microsoft Excel, Microsoft Corporation, Way Redmond,
Washington), where no information allowing identification of the
institutions, radiologists, clients, and dogs was present.
2.1 | First online survey
Approval of the American College of Veterinary Radiology (ACVR) and
European College of Veterinary Diagnostic Imaging (ECVDI) board
secretaries was sought. An e-mail containing the link to the survey
was sent directly by ACVR and ECVDI board secretaries, for privacy
purposes. The first survey was a Knowledge, Attitude and Practice
study. Before the start of the survey, a description of the aim and pur-
poses of the study were provided. We emphasized that the survey
would serve as a tool to further clinical knowledge. Radiologists were
free to answer to the survey.
The first survey was initially submitted to answer the first objective
of the study. It aimed at evaluating the percentage of veterinary radiol-
ogists performing the procedure, how frequently they performed it,
and how often complications had been noted. We also asked the rea-
sons why some radiologists were not performing FNAs on AG lesion.
For any reason other than those cited, a short answer box was pro-
vided. The first survey was sent accompanied by a brief description of
the project. Questions of the survey are documented in Appendix S1.
2.2 | Second online survey
The second survey was sent to veterinary radiologists who had per-
formed the procedure at least once in their career. This survey was
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intended to recruit cases and obtain data from the radiologists. This
second survey contained specific questions regarding the clinical
cases, referring particularly to the technique that was used and the
potential complications, in order to evaluate the incidence of adverse
events related to the procedure. Questions of the survey are docu-
mented in Appendix S2.
2.2.1 | Case selection criteria
Dogs with a unilateral or bilateral AG lesion(s) that underwent US-
guided FNA were included in this observational cross-sectional case
study if their signalment, ultrasonographic and cytological reports, and
a 48-hour follow-up were available.
2.2.2 | Medical records review
Signalment, main clinical signs, and selected clinicopathological findings
such as the presence of stress leukogram, thrombocytosis, increased
alkaline phosphatase (ALP), and urinary specific gravity, the presence of
proteinuria (through urinary protein:urinary creatinine ratio), endoge-
nous ACTH concentrations, results of an ACTH stimulation test or of a
low- or high-dose dexamethasone suppression test, systemic blood
pressure before, during and after the FNA procedure, and measure-
ments of urinary normetanephrine/urinary creatinine or serum
metanephrine concentrations were collected in an excel spreadsheet if
available and evaluated. The review of the medical records was mainly
aimed at obtaining useful information for a diagnosis of cortisol produc-
ing or catecholamine producing adrenal tumor.4-6,21-24
2.2.3 | Ultrasound reports review
From each US report and available US images, the following criteria
were collected in an excel spreadsheet and reviewed: side and size
(mm) of adrenal lesions, the dimension (mm) of the contralateral AG,
echogenicity (hypoechoic, hyperechoic, or isoechoic to adjacent adi-
pose tissue), echotexture (homogeneous, heterogeneous) and con-
tours of the lesion (smooth or irregular), presence or absence of
mineralization, and finally presence or absence of vascular inva-
sion.25,26 The contralateral AG was considered atrophied when its
maximal thickness was less than 5.0 mm.46-48 Computed tomographic
reports, when available, were also reviewed, in order to complete the
diagnostic workup. The revision of the US and CT images was at the
discretion of the radiologist who submitted the case, if the report was
not complete enough to answer to aforementioned criteria.
2.2.4 | Fine-needle aspiration procedure review
The size of the needle (diameter in gauge and length in mm), the type
of procedure (with aspiration or capillary), if other organs were
aspirated, the presence of complications post-FNA within 48 hours,
the cytological diagnosis, and, when available, the histopathological
diagnosis (post-adrenalectomy or necropsy) were collected in an excel
spreadsheet and reviewed.
2.2.5 | Statistical analysis
Descriptive methods were used to summarize findings. The data
are reported as percentages and median values (range: minimum,
maximum).
3 | RESULTS
3.1 | First online survey
The first online survey was sent to 977 board-certified radiologists. Of
these, 138 responded to the survey, which represents a 14% participation
rate. The results of the first online survey are depicted in Figure S1. The
results of the short answer box are reported in Table 1. To the fourth
TABLE 1 List of other reasons (different from those cited and
depicted in Figure 1) why veterinary radiologists would not perform





4 The results would not modify the therapeutic approach,
do not provide useful clinical information
3 Risk of hypertensive crisis in case of pheochromocytoma,
risk of hemorrhage and cytological results unreliable
2 Risk of hypertensive crisis in case of pheochromocytoma,
risk of hemorrhage
2 Risk of hypertensive crisis in case of pheochromocytoma,
not requested by clinicians
2 Not requested by clinicians
1 Risk of metastatic dissemination along the needle tract,
risk of hemorrhage, proximity of the aorta and caudal
vena cava, cytological results unreliable
1 Risk of hypertensive crisis, technically complicated
procedure
1 High risk of multiple complications
1 High risk of hemorrhage
1 Risky procedure associated to the possibility to have
nondiagnostic samples
1 If the adrenal lesion is small (3-8 mm), the procedure is
technically difficult; if the adrenal lesion is larger
(9-15 mm), it will be necessary to know if it is
functional but the surgery remains advised
1 Witnessed 1 dog dying few minutes after the procedure
1 I do not do it as I am working on mobile ultrasound
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question regarding the prevalence of complications, 15 of 67 (22%)
observed adverse reactions associated with the procedure (Figure S1D).
Of these 15, 3 radiologists did not specify the type of complication and
12 gave details about the observed complications, which are tabulated in
Table 2. Regarding procedure-related hemorrhage, 1 radiologist specified
that it was subjectively severe (but did not state if it required surgery) and
1 specified that it was mild. Regarding the 1 case of death, 1 died sud-
denly after the procedure and the other a few hours later. With the for-
mer case, a comment was added that it was a confirmed
pheochromocytoma and that the dog was already in a critical condition
before the procedure. One radiologist answered that they had never
observed complications but had heard about adverse effects from col-
leagues. One reported a case of hypertension after the FNA of a hepatic
metastasis resulting from a pheochromocytoma. Of 138 respondents,
53 (38%) were currently working in academia, 80 (58%) in private practice
or teleradiology, and 5 (4%) in both academia and private practice.
3.2 | Second online survey
The second survey was sent to 65 radiologists, from the first survey
who had performed the procedure at least once in their career (and
not only to the 40 who declared currently performing it). Twelve of
65 (18%) positive answers were obtained, that is, radiologists willing
to provide clinical cases to constitute a retrospective multicenter
study. From these 12 radiologists, 50 dogs were collected, coming
from 15 different centers (depending on where the radiologist was
working at that time). Regarding the origin of the cases, 24 of 50 dogs
were seen in the university teaching hospital or academic equivalent
and 26 of 50 dogs were seen in private practice. Cases that fulfilled
the inclusion criteria were obtained from 2003 to 2018.
3.2.1 | Signalment
Cross breed (19/50) and purebred dogs (31/50) were represented. Of
the 50 dogs, 11 were intact males, 11 castrated males, 4 intact
females, and 24 spayed females. The median age was 11 years
(4-14 years) and the median body weight was 18 kg (6-57 kg).
3.2.2 | Clinical diagnosis
In 4 of 50 dogs, the clinical signs were not available. In 6 of 46 dogs,
no abnormal clinical signs were reported and the adrenal lesion was
incidentally discovered during a senior wellness checkup. The main
clinical signs were polyuria-polydipsia (11/46), weakness (8/46), gas-
trointestinal signs (6/46), weight loss (5/46), anorexia (3/46), panting
(3/46), lethargy (3/46), alopecia (2/46), trembling (2/46), and polypha-
gia (1/46). Hypertension was observed in 3 of 46 dogs.
3.2.3 | Diagnostic imaging
In 29 of 50 dogs (58%) only the left AG, in 13 of 50 dogs (26%) only
the right AG, and in 8 of 50 dogs (16%) both AGs presented lesions.
The adrenal lesions measured between 8 and 80 mm, and the contralat-
eral AG measured between 3 and 9 mm (dogs with bilateral lesions
excluded). In 9 of 42 dogs (21%), the contralateral gland was considered
atrophied (<5.0 mm). Regarding the echogenicity of the adrenal lesions,
20 of 58 dogs were considered hyperechoic (34%), 16 of 58 hypoechoic
(28%), and 14 of 58 isoechoic (24%). Regarding the echotexture, 40 of
58 were judged heterogeneous (69%). For the contours of the adrenal
lesions, 17of 58 were described as irregularly outlined (29%), 7 of
17 lesions had a clear capsular disruption, and 41 of 58 were consid-
ered smooth and with regular contours (71%). For the presence of min-
eralization, 1 of 58 lesion had mineral foci reported (2%). Vascular
invasion was reported in 12 of 58 lesions (21%), 6 of 12 directly into
the caudal vena cava and 1 of 12 into the left renal vein. No invasion of
adjacent organs or tissues was reported. All the CT findings, when avail-
able, were consistent with the US findings and did not provide addi-
tional information regarding the presumed diagnosis.
3.2.4 | Percutaneous US-guided FNA procedure,
complications, and cytological and histopathological
diagnosis
Fifty-eight adrenal lesions from 50 dogs were aspirated (8 bilateral
adrenal lesions). The caliber of the needle used and the method per-
formed for the FNA are reported in the Figures 1 and 2. The informa-
tion regarding the needle size and method used was not available in
7 and 5 dogs, respectively. None of the dogs received treatment with
phenoxybenzamine before the FNA procedure. Blood pressure moni-
toring was performed in 17 of 50 dogs, and no hypertensive crisis was
observed in these dogs.
Cytological analysis was conclusive in 41 of 58 (71%) lesions and
nonconclusive in 17 of 58 (29%) lesions. From the 51 lesions where the
caliber of the needle was known, the cytological analysis was conclu-
sive in 33 of 43 (77%) and nonconclusive in 10 of 43 (23%) lesions
TABLE 2 List of additional complications observed following
percutaneous ultrasound-guided fine needle aspiration (FNA) of the
adrenal lesions, reported directly by veterinary radiologists, which







1 Adhesions at the FNA puncture site between the
adrenal lesion and adjacent organs/tissue. This was
observed during the adrenalectomy by the surgeon,
and complicated the surgery
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aspirated with a 22-gauge needle, conclusive in 2 of 2 lesions aspirated
with a needle smaller than 22-gauge and conclusive in 5 of 6 and non-
conclusive in 1 of 6 lesions aspirated with a needle larger than
22-gauge. From the 53 lesions where the information regarding the
FNA technique was available, the cytological analysis was conclusive in
24 of 33 (73%) and nonconclusive in 9 of 33 (27%) for the capillary
technique, conclusive in 10 of 16 and nonconclusive in 6 of 16 for the
aspiration technique, and conclusive in 3 of 4 and nonconclusive in 1 of
4 for a mixed technique (combined capillary and aspiration). Following
the cytological analysis, 23 of 41 pheochromocytoma (56%), 6 of 41 car-
cinomas (14%), 5 of 41 adenoma (12%), 3 of 41 hyperplasia (7%), 2 of
41 extramedullary hematopoiesis (5%), 1 of 41 metastasis (from anal
gland carcinoma) (2%), and 1 of 41 granuloma (from a migrating foreign
body) (2%) were diagnosed. From the 17 of 58 cytologically inconclu-
sive cases, hyperplasia and adenoma were not distinguishable in 6 of
17 cases; 6 of 17 were consistent with a neoplastic process, but identi-
fication of the tissue origin (neuroendocrine versus epithelial mainly)
was not possible; adenoma and carcinoma could not be distinguished in
3 of 17 cases, and 2 of 17 were defined as nondiagnostic sampling.
Histopathological diagnosis was available in 8 of 58 lesions; 5 of
8 histopathological reports confirmed the cytological diagnosis
(4 pheochromocytoma and 1 granuloma); 2 of 8 cytology had cor-
rectly identified cortical origin but could not definitively differentiate
adenoma (1/8) from carcinoma (1/8). Of these 8 dogs, 1 received
phenoxybenzamine before surgery, following results of the cytological
analysis of pheochromocytoma.
Four dogs (10, 12, 35, and 45) experienced a complication, rep-
resenting a complication rate of 4/50 (8%). The complication rate is
reported per dog rather than per aspirate or adrenal lesion. In the
remaining 46 of 50 dogs (92%), according to the clinical file, no
adverse reaction was encountered in the 48 hours following the pro-
cedure. Dog 10 had moderate hemorrhage from the AG immediately
after the procedure, followed by the formation of a hematoma mea-
suring 2-3 cm. The dog was a 6-year-old male castrated Dachshund
that had presented with a 3-4 cm large left adrenal mass with hetero-
geneous echogenicity and regular margins, without evidence of vascu-
lar invasion or atrophy of the contralateral gland. The procedure was
performed under sedation, by capillary using a spinal needle (22 gauge
and 63 mm in length). No other organs were aspirated during the pro-
cedure. The cytological analysis was suggestive of adenoma, and no
histopathological diagnosis was available. Information regarding the
main clinical signs or potential concomitant diseases and laboratory
findings were not available. The dog was still alive 48 hours later. Dog
12 showed tachycardia, hyperthermia, cyanotic membranes, and
death due to acute respiratory distress syndrome 28 hours after the
procedure. The dog was a 7-year-old male castrated Pyrenean Moun-
tain Dog, with a 46-mm large right adrenal mass, concurrent Wobbler
syndrome, and laryngeal paralysis. The main reported clinical signs
before FNA were weakness of the posterior limbs, panting, and fever.
A stress-leukogram, increased ALP, and low urinary specific gravity
(1012) were also present. Platelet count was within normal limits. No
coagulation profile or endocrine tests were available. The right adrenal
mass was hypoechoic, with irregular margins and disruption of the
capsule, without evidence of vascular invasion, associated with a bor-
derline atrophy (5.3 mm) of the contralateral AG. The FNA was per-
formed during general anesthesia using aspiration technique, with a
22-gauge/38-mm long needle. No other organs were aspirated during
F IGURE 2 Graph representing the method used (aspiration
versus capillary) to perform percutaneous ultrasound-guided fine-
needle aspiration of the adrenal lesions. The fine-needle aspiration
was done with capillary in 33 of 58 lesions (57%) (striped
background), with aspiration in 16 of 58 lesions (28%) (dark gray) and
with a mixed method in 4 of 58 lesions (7%) (light gray). This
information was not available for 5 of 58 (9%) lesions (black)
F IGURE 1 Graph representing the different calibers of needle
used to perform percutaneous ultrasound-guided fine-needle
aspiration of the adrenal lesions. A 22-gauge needle was used in 43 of
58 lesions (74%) (striped background), a 23-gauge needle was used in
5 of 58 lesions (9%) (white), a 25-gauge needle in 1 of 58 lesion (2%)
(black), a 16-gauge needle in 1 of 58 lesion (2%) (dark gray), and a
21-gauge needle in 1 of 58 lesion (2%) (light gray). In 7 of 58 (12%),
this information was not available (spotted background)
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the procedure. The systemic blood pressure (systolic/diastolic [mean])
was measured before and after the procedure, and were 110/60
(85) mm Hg and 90/50 (70) mm Hg, respectively. The cytological anal-
ysis was consistent with pheochromocytoma, and no histopathological
analysis was performed. Dog 35 was a mixed breed dog, male cas-
trated, 11-year-old, 9.2 kg, presented with mild weight loss, concomi-
tant cutaneous mast cell tumor, and salivary gland carcinoma. No
blood analysis was available. The dog presented with bilateral adrenal
lesions, measuring 8 and 9 mm on the left and right AGs, respectively.
Both lesions were hyperechoic and heterogeneous on US and dis-
played smooth contours. No mineralization or vascular invasion were
observed; no other ultrasonographic findings were reported regarding
the rest of the abdomen. Computed tomography features were con-
sistent with US findings with no additional information. During gen-
eral anesthesia, both adrenal lesions underwent FNA procedure using
a 30-gauge and 22-mm long needle with aspiration. Immediately after
the FNA of the right adrenal lesion, a small amount of free fluid was
noticed surrounding the adrenal, spontaneously resolved in a few
hours. The dog was alive 4 months after the FNA procedure, but tho-
racic radiographs were consistent with pulmonary metastases. Cyto-
logical analysis of the adrenal aspirates confirmed a bilateral malignant
process without distinguishing the type of tumor (pheochromocytoma
versus carcinoma). No histopathologic analysis was available. Dog
45 was a 12-year-old female intact Beagle, weighing 20 kg, presented
for diarrhea, vomiting, and hyporexia. No abnormality was observed
on available blood work. On US, the dog presented with a heteroge-
neously hyperechoic lesion deforming the cranial pole (24 × 20 mm)
of the left adrenal and a normal contralateral AG. No mineralization or
vascular invasion was noticed. The liver and spleen were slightly het-
erogeneous, but no clear solid lesions were identified. The dog under-
went, without sedation, FNA procedure of the left AG solely by
capillary technique with a 22-gauge and 38-mm long needle: immedi-
ately following the procedure, a small amount of free fluid was
observed surrounding the lesion; this was spontaneously resorbed
24 hours later during the follow-up US. The cytological analysis was
consistent with adenoma or hyperplasia. No histopathologic analysis
was performed. The dog was euthanized 3 years later for severe pan-
creatitis and aspiration pneumonia.
4 | DISCUSSION
This multicenter retrospective study confirmed that many veterinary
clinicians believe percutaneous US-guided FNA of adrenal lesions to
be unsafe.4-7 This contributes to the fact that it is not commonly
performed.
From the first survey, it emerged that two thirds of radiologists
currently do not perform FNAs of adrenal masses because of concern
of potential adverse reactions. Although studies on the subject are
limited17 with a paucity of significant data, the procedure is still not
recommended or to be performed with caution.4-7
Through the first survey it emerged that among radiologists
who have performed the procedure in the past or currently still
perform it, 78% have never encountered any complication while
22% report adverse effects. The most frequently reported compli-
cation was bleeding (7/12), followed by immediate or delayed (sev-
eral hours) death (2/12). Judging from answers given by
65 veterinary radiologists who performed the procedure at least
once in their career, at least 200 FNA of the adrenal lesions were
performed. This would imply an estimated mortality rate of about
1%. However, this estimated number might be inaccurate as it relies
on the recall of radiologists for cases over their whole career. We
may consider that radiologists are more likely to recall cases with a
bad outcome or the possibility that they might be unaware of any
complication occurring after the patient leaves the US room. There-
fore, this number should be treated with some caution and is meant
to provide to the scientific community an idea of the magnitude of
the risk.
Data acquired from the second survey showed that complications
following the procedure were reported in only 4 of 50 dogs (8%), in
which mild to moderate hemorrhage and a death (2%) due to acute
respiratory distress syndrome occurred 28 hours after the FNA proce-
dure. The latter occurred in the presence of another relevant concom-
itant disease (laryngeal paralysis). From both surveys, hypertensive
crisis was not observed in any cases where blood pressure was moni-
tored (18/50 dogs had blood pressure monitored in the second sur-
vey). Pheochromocytomas are suspected to be associated with a high
frequency of complications. A total of 23 presumed pheochromocy-
toma (based on cytological analysis) and 8 lesions with nondiagnostic
cytological analysis were sampled with FNA, and a complication
(death) was reported in only 1 dog (3%). In the veterinary literature,
there is only 1 recent reported case of adverse reaction following the
FNA procedure.17 The dog experienced ventricular tachycardia, but
the authors of that study specified that the dog presented with this
condition before the procedure, most likely due to the presence of
pericardial effusion. Consequently, the association between this
adverse reaction and the FNA procedure is questionable, and the pos-
sibility that the complication had been triggered by underlying heart
disease was suggested.
In our study, in the dogs that developed mild hemorrhage follow-
ing the FNA procedure, results of a coagulation profile were not avail-
able; therefore, it was not possible to exclude a possible correlation
between bleeding and an underlying coagulopathy.15 In these dogs,
the procedure was equally performed under sedation/general anes-
thesia and with different FNA techniques (different needle size and
different aspiration/capillary technique). In the veterinary literature, a
study was carried out on the association between abnormalities in the
coagulation profile and the risk of bleeding following an US-guided
biopsy of abdominal organs.15 This study showed that in dogs, a pro-
longed prothrombin time increased the probability of hemorrhage fol-
lowing the procedure and that thrombocytopenia predisposed to
severe hemorrhages, requiring transfusion or fluid therapy.
The dog in our study that died of respiratory distress 28 hours
following the procedure had Wobbler syndrome (caudal cervical
spondylomyelopathy) and laryngeal paralysis in addition to the adrenal
mass. The laryngeal paralysis may have contributed to the acute
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respiratory distress and is most likely the cause of death. However,
this assumption could not be verified. Cytological analysis suspected a
pheochromocytoma in this dog, raising the possibility that tachycardia
and acute respiratory distress were triggered by the release of cate-
cholamines following the aspiration of the mass. However, these com-
plications occurred 28 hours after the procedure, while the half-life of
the catecholamines is extremely short.49 Since pheochromocytoma is
a neoplasm that is often characterized by intermittent release of cate-
cholamines, the distress displayed by the dog may have been due to
the release of adrenaline and noradrenaline by the adrenal mass, inde-
pendent of the FNA procedure.
In addition to the aforementioned recently published study,17 no
other studies are available in the veterinary literature regarding com-
plications adrenal aspiration. A similar retrospective study was
recently conducted to investigate the incidence of complications of
percutaneous US-guided FNA of the pancreas in dogs.50 In this study,
the percentage of complications following the procedure was also low
(6.3%), similar to our results and those of Sumner et al (2018),
suggesting that these techniques are not as dangerous as it is com-
monly believed. Studies have been carried out in the past on US-
guided FNA of other abdominal organs, such as liver and spleen. They
concluded that this procedure is minimally invasive and almost free of
complications.51-53 Studies in human literature report that the per-
centage of complications subsequent to FNA of the liver is around
0.5% and that mortality is extremely rare (0.01%).54,55 In our study,
bleeding occurred in 1 dog in which a spinal needle (22-G; 63 mm)
was used instead of a hypodermic needle and this could have
influenced the risk of bleeding. In general, hypodermic, 22- to
25-gauge needles are commonly used for FNA of abdominal organs.1,2
In veterinary literature, the few cases of adrenal aspiration described
in the dog do not report the type of needle used. In the most recent
study,17 it is specified that because of the retrospective nature of the
study, these technical details about the procedure were not available
but that a 25-gauge/38-mm hypodermic needle is routinely used in
the clinic from which the cases were collected. No bleeding or other
complications were reported following FNA.17 There is no reference in
the literature commenting on the use of spinal needle for US-guided
FNA of abdominal organs. The additional gesture of removing the
mandrin from the spinal needle once in the adrenal lesion may have
increased the duration of the procedure, induced in situ needle move-
ment, and hence the risk of bleeding. This procedure was performed
by capillary, a technique that is considered less invasive and traumatic
to the lesion than aspiration, and consequently results in less hemodi-
lution of the sample.14 Interestingly, a higher proportion of insufficient
specimens using the capillary technique was also reported in the
same paper.14
In the human literature, it is reported that hemorrhage and pneu-
mothorax are the most frequently encountered complications follow-
ing adrenal biopsy56 and that bleeding is probably not related to the
size of the needle used, at least when the diameter is above 18- to
23-gauge (core biopsy needles, not hypodermic aspirate needles).57 It
is however difficult to extrapolate the frequency of hemorrhage and
pneumothorax from the human literature to veterinary patients
because of obviously different anatomy and technique. Interestingly,
an overall 5.3% complication rate is reported, most minor (in 666
patients across 7 studies) when a mix of FNA and needle core biopsy
techniques were used.56
For the dog with a pheochromocytoma that died after 28 hours, a
hypodermic needle of 22 gauge was used and the procedure was per-
formed by aspiration. Since other cases of pheochromocytoma under-
went FNA without complications, using both aspiration and capillary
technique, it is difficult to hypothesize that there is a correlation
between the technique (aspiration/capillary), and the release of cate-
cholamines by the pheochromocytoma. The type of needle may not
be incriminated, since the needle (hypodermic, of 22 gauge and
38 mm) was identical to most other cases of pheochromocytoma.
In the first survey, a radiologist reported the presence of adhe-
sions at the FNA puncture site between the adrenal lesion and adja-
cent organs/tissue (cf. Table 2). This was observed during the
adrenalectomy by the surgeon and complicated the surgery. Meta-
static spread along the needle tract has not been reported in dogs
with adrenal tumors but has been described in humans,16 and with
FNA of carcinomas of other origin (eg, transitional cell carcinoma).58
In our case, it was not specified whether the adjacent tissue to which
the adrenal lesion was adherent, was infiltrated by tumor or not.
Our study compared the results of the cytological examination
with the histological findings only in 8 of 58 lesions. Histology con-
firmed the cytological diagnosis in 5 of 8 lesions. However, the limited
number of available histological analyses prevented us from reaching
a conclusion with regard to the diagnostic accuracy of FNA of adrenal
lesions.
In our study, excluding the dogs in which cytological examination
reported the presence of a granuloma and extramedullary hematopoi-
esis, cytology was able to distinguish the origin of the adrenal lesion
(cortical or medullary) in 48 of 55 (87%) lesions. This confirms the
results of Bertazzolo et al,3 who demonstrated an accuracy of adrenal
cytology in differentiating cortical lesions from medullary lesions of
90% to 100%. In our study, 5 cytological reports could not reliably dis-
tinguish between an adenoma or a cortical hyperplasia; this supports
the findings of a previous publication in which differentiation between
these 2 cortical lesions through cytology alone was difficult.3 Conclu-
sions regarding the acquisition of diagnostic samples with other nee-
dle sizes were not possible in our study, due to limited numbers. It
seems that the use of a 22-gauge needle yielded a conclusive cytolog-
ical diagnosis in 77% of samples. Regarding the method used (ie, capil-
lary versus aspiration), it was not possible from these results to prove
the superiority of 1 technique over the other. Presumably, the types
of lesions sampled by each technique were not identical between the
2 groups, and this could bias the sampling outcomes. In addition, the
radiologist may have selected their technique based on vascularity/
size/access/feel of the mass, which could also impact on the results.
Although the complication rate associated with the procedure
seems low, is it worth taking the risk for the sake of a thorough clinical
workup? There are probably a few clinical situations where percutane-
ous US-guided FNA of adrenal lesions is indicated, and there is no cur-
rent consensus regarding the diagnostic workup of incidentaloma in
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dogs, despite the high incidence reported on US and CT.20,21,59 The
authors thought that the scientific community had to be informed of
the low magnitude of the risk associated with this procedure when it
is clinically indicated.
Even though 5 of 8 dogs were suspected to have pheochromocy-
toma according to cytological analysis, only 1 dog was pretreated with
phenoxybenzamine before surgery. This goes a little against 1 of the
main advantages of a presurgical FNA, as phenoxybenzamine-treated
dogs had a significantly decreased death rate compared with
untreated dogs.39
The main limitations of our study rely on the low participation
rate (14%). Although still in the range (10%-15%) of the expected par-
ticipation rate for an external survey (versus 30%-40% for internal
survey),60 one can argue that the nonresponse bias may have an
important impact on the value of these results. Although the impact
of nonresponse bias on results cannot be as easily quantified as sam-
pling error can, response rate can be used as one way to gauge the
potential for nonresponse bias. The higher the response rate of a sur-
vey, the lower the risk of nonresponse bias. Even though the partici-
pation rate remains in the “acceptable” range, the high nonresponse
bias may undermine the reliability of the results of the study, and this
is not something that we could quantify. The other main limitation of
the study is the potential selection bias in the recruitment of the
cases. Radiologists who had decided to participate in the study may
already have a strong opinion on the safety of percutaneous US-
guided FNA of adrenal lesions and decided to participate in order to
confirm their belief.61,62 In the same manner, participation to the first
survey may have been influenced by the personal conviction on the
topic and introduced a selection bias. Although we attempted not to
use leading questions type in the first survey, we cannot assess if
these questions could sway the respondents toward a particular
answer. No assumption was indicated in the title of the questions to
avoid encouraging a certain answer from the respondent.61,62 How-
ever, we provided specific options to select and despite the option for
an “other” open response, this may have lead radiologists to think that
they should be worried about, expect, or select from certain complica-
tions from the procedure. Completely open answers may have
avoided this.
5 | CONCLUSION
According to our results, percutaneous US-guided FNA of adrenal
lesions is considered a minimally risky procedure, despite veterinary
radiologists' contrary opinion. In this study, the complications rate was
similar to what has recently been published about FNAs of the adrenal
lesions and comparable to the complication rate of FNAs of other
abdominal organs. This study also confirmed good diagnostic accuracy
of adrenal cytology in distinguishing neoplasms of cortical origin from
those of medullary origin, indicating its relevance in the diagnostic
workup of an adrenal lesion. Larger prospective studies would be rec-
ommended to investigate this technique in more detail, in order to draw
additional conclusions in terms of safety and diagnostic accuracy.
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